President and Chief Medical Officer, Peplin, Inc.
| Role | Organisation | Sources |
|---|---|---|
| President and Chief Medical Officer | Peplin, Inc. | GBS Ventures (12 Nov 2009), GBS Ventures (18 Aug 2008) |
Stories naming Dr Eugene Bauer. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
LEO Pharma's acquisition of Peplin is done, a deal agreed in September 2009 for about US$287.5 million. Peplin continues as a LEO subsidiary led by chief executive George Mahaffey, keeping Australian operations.
Also GBS Ventures
Peplin hires Tom Wiggans as CEO and Eugene Bauer as President/CMO while Michael Aldridge steps down; the dermatology company also announces a US$24m capital raising and a merger agreement with Neosil.